These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23857817)

  • 1. Low-dose escitalopram-associated hyponatremia.
    Pae CU; Park GY; Im S; Ko SB; Lee SJ
    Asia Pac Psychiatry; 2013 Jun; 5(2):E90. PubMed ID: 23857817
    [No Abstract]   [Full Text] [Related]  

  • 2. Escitalopram in the treatment of major depressive disorder in adolescent patients. Profile report.
    Yang LP; Scott LJ
    CNS Drugs; 2010 Jul; 24(7):621-3. PubMed ID: 20527998
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of SIADH and hyponatremia associated with citalopram.
    Bourgeois JA; Babine SE; Bahadur N
    Psychosomatics; 2002; 43(3):241-2. PubMed ID: 12075041
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective dose of escitalopram in moderate versus severe DSM-IV major depression.
    Bech P; Andersen HF; Wade A
    Pharmacopsychiatry; 2006 Jul; 39(4):128-34. PubMed ID: 16871468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyponatremia and probable inappropriate secretion of antidiuretic hormone due to citalopram].
    Pradalier A; Devars du Mayne JF; Barzegar C; Vincent D
    Therapie; 1998; 53(6):600-2. PubMed ID: 10070243
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
    Trivedi MH; Cutler AJ; Richards C; Lasser R; Geibel BB; Gao J; Sambunaris A; Patkar AA
    J Clin Psychiatry; 2013 Aug; 74(8):802-9. PubMed ID: 24021497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
    Colonna L; Andersen HF; Reines EH
    Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choreatic symptoms during and after treatment with paliperidone and escitalopram.
    Hüther R; Gebhart C; Mirisch S; Bäuml J; Förstl H
    Pharmacopsychiatry; 2008 Sep; 41(5):203-4. PubMed ID: 18763225
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary retention with a high dose of escitalopram.
    Garakani A
    Gen Hosp Psychiatry; 2010; 32(6):e11-2. PubMed ID: 21112445
    [No Abstract]   [Full Text] [Related]  

  • 12. [Citalopram].
    Taéron C
    Rev Infirm; 2008 Nov; (145):47-9. PubMed ID: 19044198
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.
    Schmitt L; Tonnoir B; Arbus C
    Neuropsychobiology; 2006; 54(4):201-7. PubMed ID: 17337913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delirium and multiple electrolyte abnormalities associated with high dose paroxetine exposure.
    Chuang YF; Chiu YL; Hwang TJ; Chu TS
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):642-3. PubMed ID: 16958954
    [No Abstract]   [Full Text] [Related]  

  • 15. Unfavorable smell with citalopram?
    Ghanizadeh A
    J Clin Psychopharmacol; 2007 Oct; 27(5):528-9. PubMed ID: 17873697
    [No Abstract]   [Full Text] [Related]  

  • 16. Citalopram-associated spontaneous ejaculations.
    Virit O; Savas HA
    J Clin Psychopharmacol; 2008 Jun; 28(3):360-1. PubMed ID: 18480704
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe bradycardia in a stroke patient caused by a single low dose of escitalopram.
    Beyenburg S; Schönegger K
    Eur Neurol; 2007; 57(1):50-1. PubMed ID: 17114884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe and recent hyponatremia and hypokalemia associated to the use of hydrochlorothiazide, enalapril and citalopram. Clinical case].
    Riquelme A; Méndez F; Ortiz AM; Müller H; Campos C; Rocha V; Valdivieso A
    Rev Med Chil; 1999 Oct; 127(10):1223-8. PubMed ID: 10835739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia associated with escitalopram.
    Covyeou JA; Jackson CW
    N Engl J Med; 2007 Jan; 356(1):94-5. PubMed ID: 17202465
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
    Wand AP
    Aust N Z J Psychiatry; 2012 Feb; 46(2):178. PubMed ID: 22311539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.